IS8360A - Mótlyf styrkthjöppunarhormóns melaníns - Google Patents
Mótlyf styrkthjöppunarhormóns melanínsInfo
- Publication number
- IS8360A IS8360A IS8360A IS8360A IS8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A IS 8360 A IS8360 A IS 8360A
- Authority
- IS
- Iceland
- Prior art keywords
- antagonist
- melanin concentration
- concentration hormone
- hormone
- melanin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/79—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a ring other than a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US50777303P | 2003-10-01 | 2003-10-01 | |
US53664004P | 2004-01-15 | 2004-01-15 | |
PCT/US2004/031631 WO2005033063A2 (en) | 2003-10-01 | 2004-09-24 | Melanin concentrating hormone antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
IS8360A true IS8360A (is) | 2006-03-17 |
Family
ID=34426018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS8360A IS8360A (is) | 2003-10-01 | 2006-03-17 | Mótlyf styrkthjöppunarhormóns melaníns |
Country Status (20)
Country | Link |
---|---|
US (1) | US7304065B2 (is) |
EP (1) | EP1667958A2 (is) |
JP (1) | JP2007508303A (is) |
KR (1) | KR20060060047A (is) |
CN (1) | CN101068773A (is) |
AR (1) | AR045958A1 (is) |
AU (1) | AU2004278352B2 (is) |
BR (1) | BRPI0415051A (is) |
CA (1) | CA2540826A1 (is) |
CO (1) | CO5690589A2 (is) |
IL (1) | IL174370A0 (is) |
IS (1) | IS8360A (is) |
MA (1) | MA28079A1 (is) |
MX (1) | MXPA06003654A (is) |
NO (1) | NO20061953L (is) |
PE (1) | PE20050475A1 (is) |
RU (1) | RU2006110272A (is) |
SG (1) | SG146692A1 (is) |
TW (1) | TW200526554A (is) |
WO (1) | WO2005033063A2 (is) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001160A1 (en) * | 2006-06-23 | 2008-01-03 | The Procter & Gamble Company | Melanin concentrating hormone antagonists |
US7700599B2 (en) * | 2006-06-28 | 2010-04-20 | Glaxo Group Limited | Gpr38 Receptor Agonists |
WO2008044632A1 (fr) * | 2006-10-06 | 2008-04-17 | Taisho Pharmaceutical Co., Ltd. | Dérivé de la 1-naphthyl alkylpipéridine |
WO2008134048A2 (en) * | 2007-04-27 | 2008-11-06 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
EP2025674A1 (de) * | 2007-08-15 | 2009-02-18 | sanofi-aventis | Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
WO2009153720A1 (en) * | 2008-06-18 | 2009-12-23 | Pfizer Limited | Nicotinamide derivatives |
AR075401A1 (es) | 2009-02-13 | 2011-03-30 | Sanofi Aventis | Indanos sustituidos, procesos para su preparacion y uso de los mismos como un medicamento |
AR075402A1 (es) * | 2009-02-13 | 2011-03-30 | Sanofi Aventis | Derivados heterociclicos oxigenados y/o nitrogenados de tetrahidronaftaleno, medicamentos que los contienen y uso de los mismos en el tratamiento de trastornos metabolicos, tales como obesidad,entre otros. |
WO2011083804A1 (ja) * | 2010-01-06 | 2011-07-14 | 武田薬品工業株式会社 | インドール誘導体 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5206428A (en) * | 1989-11-16 | 1993-04-27 | Tanabe Seiyaku Co., Ltd. | Tetrahydronaphthalene derivatives and preparation thereof |
ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
WO1994018204A1 (en) * | 1993-02-12 | 1994-08-18 | Merck & Co., Inc. | Spiro (2h-1-benzopyran-2, 4' piperidine) class iii antiarrhythmics |
WO1994027597A1 (en) | 1993-05-21 | 1994-12-08 | Smithkline Beecham Corporation | Imidazolyl-alkenoic acid angiotensin ii receptor antagonists |
US5756496A (en) | 1994-05-28 | 1998-05-26 | Smithkline Beecham P.L.C. | Amide derivatives having 5HT1D-antagonist activity |
DE4438029A1 (de) * | 1994-10-25 | 1996-05-02 | Thomae Gmbh Dr K | N.N-disubstituierte Benzocycloalkylamine, ihre Salze mit verträglichen organischen oder anorganischen Säuren, Verfahren zur Herstellung dieser Verbindungen und diese enthaltende Arzneimittel |
US6008219A (en) | 1995-03-27 | 1999-12-28 | Smithkline Beech P.L.C. | Bicyclic amine derivatives and their use as anti-psychotic agents |
DE19614718A1 (de) * | 1996-04-15 | 1997-10-16 | Hoechst Schering Agrevo Gmbh | Substituierte Pyridine/Pyrimidine, Verfahren zu ihrer Herstellung, und ihre Verwendung als Schädlingsbekämpfungsmittel |
HU225960B1 (en) | 1997-02-27 | 2008-01-28 | Takeda Pharmaceutical | Amine compounds, their production and use |
WO2000009480A1 (fr) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Nouveaux derives sulfonyle |
WO2001021577A2 (en) * | 1999-09-20 | 2001-03-29 | Takeda Chemical Industries, Ltd. | Melanin concentrating hormone antagonist |
AU2001252596A1 (en) | 2000-04-28 | 2001-11-12 | Takeda Chemical Industries Ltd. | Melanin concentrating hormone antagonists |
US7229986B2 (en) | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
CA2431953A1 (en) | 2000-12-22 | 2002-07-04 | Schering Corporation | Piperidine mch antagonists and their use in the treatment of obesity |
US6900329B2 (en) | 2001-03-21 | 2005-05-31 | Schering Corporation | MCH antagonists and their use in the treatment of obesity |
US7544690B2 (en) | 2001-10-01 | 2009-06-09 | Taisho Pharmaceutical Co., Ltd. | MCH receptor antagonists |
AU2002337956B2 (en) | 2001-10-25 | 2006-02-23 | Schering Corporation | MCH Antagonists for the treatment of obesity |
ES2333415T3 (es) | 2001-11-26 | 2010-02-22 | Schering Corporation | Antagonistas de la mch basados en piperidina para el tratamiento de la obesidad y de trastornos del snc. |
JP2005518365A (ja) | 2001-11-27 | 2005-06-23 | メルク エンド カムパニー インコーポレーテッド | 4−アミノキノリン化合物 |
AU2002352878B2 (en) | 2001-11-27 | 2007-11-22 | Merck Sharp & Dohme Corp. | 2-Aminoquinoline compounds |
KR20050044664A (ko) | 2001-12-04 | 2005-05-12 | 쉐링 코포레이션 | 비만 치료용 mch 길항제로서의n-아릴-n'-아릴사이클로알킬-우레아 유도체 |
DE10238865A1 (de) | 2002-08-24 | 2004-03-11 | Boehringer Ingelheim International Gmbh | Neue Carbonsäureamid-Verbindungen mit MCH-antagonistischer Wirkung, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
BR0315566A (pt) * | 2002-10-21 | 2005-08-23 | Janssen Pharmaceutica Nv | Tetralinas e indanos substituìdos |
JP2006522825A (ja) * | 2003-04-10 | 2006-10-05 | アムジェン インコーポレイテッド | ブラジキニンレセプター親和性を有する二環式化合物およびその薬学的組成物 |
-
2004
- 2004-09-24 SG SG200807343-9A patent/SG146692A1/en unknown
- 2004-09-24 JP JP2006533994A patent/JP2007508303A/ja active Pending
- 2004-09-24 MX MXPA06003654A patent/MXPA06003654A/es unknown
- 2004-09-24 US US10/949,841 patent/US7304065B2/en not_active Expired - Fee Related
- 2004-09-24 BR BRPI0415051-1A patent/BRPI0415051A/pt not_active IP Right Cessation
- 2004-09-24 EP EP04789086A patent/EP1667958A2/en not_active Withdrawn
- 2004-09-24 CA CA002540826A patent/CA2540826A1/en not_active Abandoned
- 2004-09-24 WO PCT/US2004/031631 patent/WO2005033063A2/en not_active Application Discontinuation
- 2004-09-24 CN CNA2004800284489A patent/CN101068773A/zh active Pending
- 2004-09-24 RU RU2006110272/04A patent/RU2006110272A/ru not_active Application Discontinuation
- 2004-09-24 AU AU2004278352A patent/AU2004278352B2/en not_active Expired - Fee Related
- 2004-09-24 KR KR1020067006228A patent/KR20060060047A/ko not_active Application Discontinuation
- 2004-09-30 AR ARP040103561A patent/AR045958A1/es not_active Application Discontinuation
- 2004-09-30 TW TW093129687A patent/TW200526554A/zh unknown
- 2004-10-01 PE PE2004000964A patent/PE20050475A1/es not_active Application Discontinuation
-
2006
- 2006-03-16 IL IL174370A patent/IL174370A0/en unknown
- 2006-03-17 IS IS8360A patent/IS8360A/is unknown
- 2006-03-31 MA MA28903A patent/MA28079A1/fr unknown
- 2006-04-11 CO CO06035263A patent/CO5690589A2/es not_active Application Discontinuation
- 2006-05-02 NO NO20061953A patent/NO20061953L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2007508303A (ja) | 2007-04-05 |
IL174370A0 (en) | 2006-08-01 |
RU2006110272A (ru) | 2007-11-10 |
MXPA06003654A (es) | 2006-06-05 |
BRPI0415051A (pt) | 2006-11-28 |
US20050075324A1 (en) | 2005-04-07 |
NO20061953L (no) | 2006-06-13 |
KR20060060047A (ko) | 2006-06-02 |
WO2005033063A2 (en) | 2005-04-14 |
TW200526554A (en) | 2005-08-16 |
CA2540826A1 (en) | 2005-04-14 |
CN101068773A (zh) | 2007-11-07 |
MA28079A1 (fr) | 2006-08-01 |
AU2004278352B2 (en) | 2008-10-30 |
EP1667958A2 (en) | 2006-06-14 |
WO2005033063A3 (en) | 2007-03-22 |
SG146692A1 (en) | 2008-10-30 |
AR045958A1 (es) | 2005-11-16 |
AU2004278352A1 (en) | 2005-04-14 |
PE20050475A1 (es) | 2005-10-05 |
US7304065B2 (en) | 2007-12-04 |
CO5690589A2 (es) | 2006-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004017700D1 (de) | Transmukosen verabreichung | |
NO20034702D0 (no) | Elektrode | |
ATE354631T1 (de) | Nuancierungsmittel | |
DE60315135D1 (de) | Therapiesonde | |
ATE394659T1 (de) | Probenhomogenisator | |
DK1667992T3 (da) | Quinazolinderivater | |
IS8360A (is) | Mótlyf styrkthjöppunarhormóns melaníns | |
NO20035142D0 (no) | N¶rhetsdetektor | |
ATE333271T1 (de) | Uv-stabiles transdermales pflaster | |
NO20055143D0 (no) | Doseringsformer innbefattende AG013736 | |
DK1597171T3 (da) | Terapeutisk mikroskum | |
NO20034599L (no) | Brokonstruksjon | |
DE602004014239D1 (de) | Betoniereinrichtung | |
ATA2792002A (de) | Temperaturfühler | |
NO20034600D0 (no) | Brokonstruksjon | |
ATE439379T1 (de) | Chimärer antagonist anth1 | |
NO20041286L (no) | Gulvavlop | |
ATA2722003A (de) | Schalung | |
NO20032032D0 (no) | V¶skepumpe | |
FR2849788B1 (fr) | Melangeur | |
FI20021817A (fi) | Kanyyli | |
FI20031158A (fi) | Inhalaattori | |
DE112004001429D2 (de) | Pharmazeutischer Wirkstoff | |
ATA12882003A (de) | Osteosynthesevorrichtung | |
ATE374639T1 (de) | Elektrotherapievorrichtung |